Astrazeneca Stops Cholesterol Drug Trial Because Of Promising Results
Pharmaceutical giant AstraZeneca announced yesterday, Monday 31st March, it was stopping the JUPITER clinical trial on its cholesterol-busting drug Crestor (rosuvastatin calcium) because early findings showed that the drug reduced deaths and risk of heart problems in patients compared to placebo.
More: continued here
Filed under: Cholesterol on April 2nd, 2008